The 12 closest competitors and alternatives to Atelerix among healthtech companies — ranked by similarity to what Atelerix actually does, not by market-cap band.
Subscribe to see Atelerix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.
Atelerix is a healthtech company headquartered in United Kingdom, founded in 2017. It has raised at least $2.2M across the 3 funding rounds on record. Its most recent funding round, Pre-Seed, raised $932,856 in January 2025. Xcout tracks 7 named people at Atelerix, including Alastair Carrington (CEO).
1 more named person on record for Atelerix, with roles, board committees and tenure — see the full roster →
At least $2.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $932,856 | 3 named | |
| Seed | $700,000 | — | |
| Seed | $553,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Atelerix by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
CryoStasis is a biotechnology company headquartered in Ottawa, Canada, specializing in the subzero unfrozen bio-preservation of cells, tissues, and organs.
Biotechnology
AcroCyte Therapeutics, Inc. is a biotechnology company dedicated to overcoming common laboratory challenges through its proprietary R³CE rapid, reproducible, rare cell 3D expansion technology. Recognized with awards such as the Taiwan National Innovation Award, the company focuses on advancing biomedical research and cell-based applications.
Biotechnology
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
Biotechnology / Drug Delivery
Jurata Thin Film is a biotechnology firm specializing in innovative thin film technology designed to revolutionize biological sample storage and stabilization. The company maintains corporate operations and research facilities in Chapel Hill, North Carolina, and Houston, Texas.
Biotechnology
RJH Biosciences develops transfection reagents and nucleic acid delivery systems for various human cells, cell lines, and preclinical animal models. The company serves the biomedical research and development sector by providing tailored products and contract research services for applications such as mRNA, DNA, siRNA, and CRISPR delivery.
Health Care
Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.
Biotechnology
Atley Solutions is a global leader in commercial products and services for astatine-related (At-211) radiopharmaceutical development and scalable manufacturing, originating from research at the University of Gothenburg.
Biotech
StemCyte is a global cord blood banking and regenerative therapeutics company that provides public and private umbilical cord blood and cord tissue preservation services for expectant families. The company processes, tests, and cryopreserves stem cells for family protection and clinical use, and supplies cellular materials for transplants and medical research.
Biotech
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Medical Technology
4D Biomaterials is a UK medical-technology company developing bioresorbable polymer materials for medical devices and tissue-engineering applications. Its materials are intended to support applications such as 3D-printed implants and regenerative medicine, serving medical-device manufacturers and healthcare markets.
Health Tech / Bio
HexemBio is a health technology company developing regenerative therapies based on a Synthetic Human Yolk Sac technology designed to rejuvenate aging blood stem cells. Its lead program focuses on improving bone marrow transplant outcomes for blood cancer patients to extend healthy lifespan.
Biotechnology & Medical Technology
Tiger Biotherapeutics Inc. is a regenerative medicine company that develops and provides advanced cellular, acellular, and matrix-like products (CAMPs) for wound care, aesthetics, and tissue science. The company serves healthcare providers and patients by offering solutions for tissue repair, wound closure, and reconstructive or cosmetic applications.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Atelerixand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →